The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.

Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients.

The TAT Congress series has effectively transformed the landscape of early drug development and become a highly influential meeting.